Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Novartis Ag ADR (NVS)

Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 224,696,928
  • Shares Outstanding, K 2,044,000
  • Annual Sales, $ 46,660 M
  • Annual Income, $ 14,850 M
  • 60-Month Beta 0.57
  • Price/Sales 4.92
  • Price/Cash Flow 9.69
  • Price/Book 5.25
Trade NVS with:

Options Overview Details

View History
  • Implied Volatility 17.58% ( +0.14%)
  • Historical Volatility 18.44%
  • IV Percentile 55%
  • IV Rank 39.49%
  • IV High 25.21% on 04/19/24
  • IV Low 12.60% on 05/16/24
  • Put/Call Vol Ratio 11.25
  • Today's Volume 1,188
  • Volume Avg (30-Day) 3,144
  • Put/Call OI Ratio 1.59
  • Today's Open Interest 47,806
  • Open Int (30-Day) 59,410

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 1.88
  • Number of Estimates 4
  • High Estimate 1.96
  • Low Estimate 1.78
  • Prior Year 1.74
  • Growth Rate Est. (year over year) +8.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
105.72 +4.35%
on 07/19/24
112.48 -1.92%
on 07/12/24
+3.25 (+3.04%)
since 06/26/24
3-Month
96.71 +14.07%
on 05/01/24
112.48 -1.92%
on 07/12/24
+12.88 (+13.22%)
since 04/26/24
52-Week
92.19 +19.67%
on 10/27/23
112.48 -1.92%
on 07/12/24
+6.43 (+6.19%)
since 07/26/23

Most Recent Stories

More News
Novartis Ag (NVS) Q2 2024 Earnings Call Transcript

NVS earnings call for the period ending June 30, 2024.

NVS : 110.32 (+0.35%)
Why Novartis Stock Is Down Today Despite Topping Q2 Estimates

Investors were caught off guard by a decision on the research and development front.

NVS : 110.32 (+0.35%)
2 Magnificent Stocks to Buy With $500

These reliable healthcare companies look attractive no matter how you slice it.

MRK : 125.26 (-0.47%)
NVS : 110.32 (+0.35%)
Wholesale Trade, Housing Starts Next Week

Monday U.S. Featured Earnings Goldman Sachs Group Inc. (NYSE:GS) (Q2) EPS of $8.70, compared ...

GS : 499.03 (+1.49%)
HDB : 60.64 (+0.73%)
BLK : 856.20 (+2.35%)
UNH : 569.72 (+1.79%)
BAC : 41.67 (-0.02%)
MS : 104.19 (+0.61%)
ASML : 888.39 (+2.99%)
JNJ : 160.64 (+0.63%)
ELV : 527.50 (+2.62%)
NFLX : 631.37 (-0.43%)
NVS : 110.32 (+0.35%)
ABT : 105.24 (-0.68%)
Novartis Canada launches $500,000 funding initiative to improve health equity in Canada

/CNW/ - Novartis Pharmaceuticals Canada Inc. (Novartis) today announced the launch of a new health equity initiative, aimed at addressing health disparities...

NVS : 110.32 (+0.35%)
The Novartis Oncology Young Canadian Investigator Awards (NOYCIA) returns for its 21st year at ASCO 2024

/CNW/ - Novartis Canada is pleased to announce the winners of the 2024 Novartis Oncology Young Canadian Investigator Awards (NOYCIA), an annual national...

NVS : 110.32 (+0.35%)
NOVARTIS CANADA AND CLARIUS MOBILE HEALTH CHALLENGE STANDARD OF CARE FOR PSORIATIC ARTHRITIS WITH NEW PARTNERSHIP

Psoriatic arthritis is a chronic, autoimmune disease form of arthritis that causes joint inflammation (swelling, pain, stiffness) and occurs with skin...

NVS : 110.32 (+0.35%)
AAPL : 217.96 (+0.22%)
Health Canada approves Cosentyx®, a biologic therapy, for the treatment of adults with moderate to severe Hidradenitis Suppurativa (HS)

/CNW/ - Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that Health Canada has granted Cosentyx® (secukinumab) with a Notice of...

NVS : 110.32 (+0.35%)
3 Magnificent Stocks That Are Passive Income Machines

These three companies have track records that should please investors.

LLY : 804.62 (-2.02%)
ABBV : 185.16 (+1.64%)
NVS : 110.32 (+0.35%)
2 Magnificent Dividend Stocks to Hold for the Next Decade

The dividend is just one reason to buy these stocks.

NVS : 110.32 (+0.35%)
V : 259.46 (+2.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Novartis has one of the strongest and broadest portfolio of oncology drugs and generics. It continues to build depth in 5 core therapeutic areas Cardio-Renal, Immunology, Neuroscience, Oncology and Hematology, strength in technology platforms - Targeted Protein Degradation, Cell Therapy, Gene Therapy,...

See More

Key Turning Points

3rd Resistance Point 111.77
2nd Resistance Point 111.22
1st Resistance Point 110.77
Last Price 110.32
1st Support Level 109.77
2nd Support Level 109.22
3rd Support Level 108.77

See More

52-Week High 112.48
Last Price 110.32
Fibonacci 61.8% 104.73
Fibonacci 50% 102.34
Fibonacci 38.2% 99.94
52-Week Low 92.19

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar